Literature DB >> 6450237

Inhibition of murine humoral immune responses by substances derived from trypanosomes.

J W Albright, J F Albright.   

Abstract

Previous studies of depressed immune responses in mice infected with the mouse-specific Trypanosoma musculi have produced no evidence of major involvement of typical suppressor lymphocytes or macrophages. We continue this line of investigation in the present report by demonstrating that: a) T. musculi strongly suppress the responses of nude mouse spleen cells to the T-independent antigen, TNP-LPS; b) spleen cell preparations of infected mice display a substantial proportion of cells bearing trypanosome-derived substances (TDS) demonstrable by specific rabbit antibody against T. musculi (RATS); c) treatment of spleen cells from infected mice with RATS plus C eliminates the inhibitory effect of these spleen cells on the immune responses of co-cultivated normal spleen cells; d) incubation in vitro of normal spleen cells with an extract of T. musculi results in progressive loss of the cells to respond to antigens and, in addition, confers on the treated cells to respond to antigens and, in addition, confers on the treated cells the property of inhibiting the responses of co-cultivated normal spleen cells; e) T. lewisi, the rat-specific trypanosome, fails to inhibit murine immune responses. We conclude that the immunoinhibitory effects of T. musculi on murine immune responses are associated with the cytophilic binding of TDS (possibly in the form of immune complexes) and that this vigorous mechanism of inhibition will be shown to involve nonspecific mitogenic and/or biosynthetic activation of lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6450237

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Suppressor factor of T-cell activation and decreased interleukin 2 activity in experimental African trypanosomiasis.

Authors:  A Alcina; M Fresno
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

2.  Incubation of trypanosome-derived mitogenic and immunosuppressive products with peritoneal macrophages allows recovery of biological activities from soluble parasite fractions.

Authors:  D L Sacks; G Bancroft; W H Evans; B A Askonas
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

3.  Trypanosome infection of mice depresses antibody affinity and delays affinity maturation.

Authors:  J R Pattison; M W Steward; G A Targett
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

4.  Differences in resistance to Trypanosoma musculi infection among strains of inbred mice.

Authors:  J W Albright; J F Albright
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

5.  Cellular responses to culture-derived soluble exoantigens of Trypanosoma lewisi.

Authors:  C M Ndarathi
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

6.  Histopathological and immunocytochemical studies of Trypanosoma musculi infection of mice.

Authors:  K Hirokawa; Y Eishi; J W Albright; J F Albright
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

7.  In vitro induction of human helper T cell activity by Trypanosoma brucei.

Authors:  M E Selkirk; S R Wilkins; B M Ogilvie; T A Platts-Mills
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

8.  Interleukin-1 and interleukin-2 production in resistant and susceptible inbred mice infected with Trypanosoma congolense.

Authors:  L A Mitchell; T W Pearson; J Gauldie
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

9.  Natural killer activity in mice infected with Trypanosoma musculi.

Authors:  J W Albright; K Y Huang; J F Albright
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

10.  The availability of purines influences both the number of parasites and the splenocyte levels of purine-metabolizing enzymes in trypanosome-infected mice.

Authors:  J W Albright; J F Albright
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.